EGFR tyrosine kinase inhibitors in non-small cell lung cancer: report of a 3-year compassionate use experience with gefitinib in stage IIIB/IV outpatients.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DF975B2C.svg?ark=w1%2F20260515%2FDF975B2C)](https://nobleid.org/work/w1/20260515/DF975B2C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors